BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18442561)

  • 1. Cellular immunity impaired among patients on left ventricular assist device for 6 months. Invited commentary.
    Conte J
    Ann Thorac Surg; 2008 May; 85(5):1661. PubMed ID: 18442561
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular immunity impaired among patients on left ventricular assist device for 6 months.
    Kimball PM; Flattery M; McDougan F; Kasirajan V
    Ann Thorac Surg; 2008 May; 85(5):1656-61. PubMed ID: 18442560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of extensive surgical intervention on cellular immune response].
    Faist E; Markewitz A; Storck M; Ertel W; Schildberg FW
    Internist (Berl); 1992 Jun; 33(6):370-8. PubMed ID: 1628923
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.
    Cleveland JC; Grover FL; Fullerton DA; Campbell DN; Mitchell MB; Lindenfeld J; Wolfel EE; Lowes BD; Shakar SF; Brieke A; Cannon A; Robertson AD
    J Thorac Cardiovasc Surg; 2008 Sep; 136(3):774-7. PubMed ID: 18805284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of immunologic reactions for wound healing].
    Ulrichs K; Eckstein V; Thiede A
    Zentralbl Chir; 1996; 121 Suppl():15-7. PubMed ID: 8967224
    [No Abstract]   [Full Text] [Related]  

  • 8. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices.
    Crow S; John R; Boyle A; Shumway S; Liao K; Colvin-Adams M; Toninato C; Missov E; Pritzker M; Martin C; Garry D; Thomas W; Joyce L
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):208-15. PubMed ID: 19154927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic aspects of normal and disordered wound healing].
    Echtenacher B
    Zentralbl Chir; 1996; 121 Suppl():18-9. PubMed ID: 8967225
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfusion-induced immunosuppression and perioperative infections.
    Tartter PI
    Beitr Infusionsther; 1993; 31():52-63. PubMed ID: 7693265
    [No Abstract]   [Full Text] [Related]  

  • 12. [Causes of organ failure in infection].
    Bartels H; Stadler J; Barthlen W; Miedtke T; Siewert JR
    Zentralbl Chir; 1994; 119(3):168-74. PubMed ID: 8178582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of left ventricular assist device infection on post-transplant outcomes.
    Schulman AR; Martens TP; Russo MJ; Christos PJ; Gordon RJ; Lowy FD; Oz MC; Naka Y
    J Heart Lung Transplant; 2009 Mar; 28(3):237-42. PubMed ID: 19285614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Invited commentary.
    Lodge AJ
    Ann Thorac Surg; 2008 May; 85(5):1650. PubMed ID: 18442557
    [No Abstract]   [Full Text] [Related]  

  • 16. Invited commentary.
    Hendry P
    Ann Thorac Surg; 2007 Aug; 84(2):520-1. PubMed ID: 17643628
    [No Abstract]   [Full Text] [Related]  

  • 17. Invited commentary.
    Tabuchi N
    Ann Thorac Surg; 2009 May; 87(5):1425. PubMed ID: 19379879
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet dysfunction in outpatients with left ventricular assist devices.
    Steinlechner B; Dworschak M; Birkenberg B; Duris M; Zeidler P; Fischer H; Milosevic L; Wieselthaler G; Wolner E; Quehenberger P; Jilma B
    Ann Thorac Surg; 2009 Jan; 87(1):131-7. PubMed ID: 19101285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modifications in immune status in children with an acute surgical infection].
    Kutubidze RA; Dawitaja GS; Korsatija BM
    Padiatr Grenzgeb; 1991; 30(5):433-6. PubMed ID: 1945460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.